Category: Zacks Small Cap Research
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update KOL Event for Alzheimer’s Program On July 8, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) conducted a Key Opinion Leader (KOL) webinar to discuss the company’ ...
By Brian Marckx, CFANASDAQ:MTBC READ THE FULL MTBC RESEARCH REPORT MTBC Makes Largest Acquisition To-Date. Meridian Medical Mgmt Co Purchase Closed June 16th MTBC, Inc. (NASDAQ:MTBC) made its largest acquisition to-date, closing on its purchase of Me ...
By David Bautz, PhDTSX:APLI.V READ THE FULL APLI.V RESEARCH REPORT Business Update Appili Therapeutics Inc. (TSX:APLI.V) is a biopharmaceutical company devoted to acquiring and developing novel treatments for infectious diseases. The company was foun ...
By David Bautz, PhDNASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update FDA Approves Clinical Plan for MN-166 to Prevent ARDS Caused by COVID-19 On July 1, 2020, MediciNova, Inc. (NASDAQ:MNOV) announced that the company’s Investigational Ne ...
By Ann Heffron, CFA, CPAOTC:CPKF READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial's (OTC:CPKF) first quarter net earnings rose $0.4 million, or 13%, year over year to $3.4 million, while 2020’s first quarter diluted EPS increased by $0.08, or ...
By John Vandermosten, CFANASDAQ:ACHV On Monday, Achieve Life Sciences, Inc. (NASDAQ:ACHV) updated the investment community on the status of New Zealand’s RAUORA1 study, which was expected to announce completion in the months leading up to the Se ...
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 DOM-INNATE Trial Fully Enrolled On June 24, 2020, Soligenix, Inc. (NASDAQ:SNGX) announced that enrollment has completed in the Phase 3 DOM-INNATE (Dusquetide tr ...
By Ian Gilson, PhD, CFANASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio (NASDAQ:MBII) has announced that Regalia is the leading biofungicide in California, with a market share of over 25% in the leaf biofungicide treatment market, for the J ...
By John Vandermosten, CFATSX:HBP.TO On June 23, 2020, Proactive hosted its One2One Virtual Forum, featuring several biotech company updates on their clinical programs. Presenting on behalf of Helix BioPharma (TSX:HBP.TO) was Dr. Heman Chao, CEO and D ...
By Anita Dushyanth, PhDNASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer’s disease Both scientists and physicians are still wrestling with the idea of how to identify the biological drivers that are responsible for the ...